← Leaderboards
Charlie E.c. Yeh
Mfluidx, Inc.
$1,798,822
Attributed
$1,798,822
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $797.1K · FY2018–20$1M$750K$500K$250K$0
'18
'19
'20
Funding mix
By agency
NIH$1,798,822 · 2
By mechanism
R44$1,499,999 · 1
R43$298,823 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Future”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$128,483,161
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
Research focus
FutureMedicalDetectionFluorescenceInterviewMalariaCommercializationDesignCommunitiesDiagnosticCostInnovation CorpsCause Of DeathMacrolidesAntibioticsCenters For Disease Control And Prevention (U.S.)Cessation Of LifeClinic VisitsChildAutomationDiagnosisClinicBaseMicrofluidics
Grant awards (3)
Point-of-care Microfluidic Diagnostic for Outpatient Clinics$797,077
R44 · FY2020 · AI · contact PI
Point-of-care Microfluidic Diagnostic for Outpatient Clinics$702,922
R44 · FY2019 · AI · contact PI
Point-of-care microfluidic nucleic acid amplification test for primary care$298,823
R43 · FY2018 · AI · contact PI